A COVID-19 check that takes 15 minutes and may be run with out lab tools was simply granted emergency use authorization by the Food and Drug Administration. It will value $5, and runs on a easy card that makes use of the identical expertise as a being pregnant check.
The check, referred to as BinaxNOW, is produced by the well being care firm Abbott. The firm can be launching an app that syncs up with the exams, and offers individuals who check destructive for the virus a “digital health pass” that they will show on their cellphone. CEO Robert Ford stated in a press release that the mixture of the check and the app provide a “comprehensive testing solution.”
The firm stated in a press launch that it plans to supply 50 million exams per 30 days by October.
“Due to its simpler design and the large number of tests the company anticipates making in the coming months, this new antigen test is an important advancement in our fight against the pandemic,” stated Jeff Shuren, director of the FDA Center for Devices and Radiological Health, in a press release.
Abbott will get EUA for his or her lateral stream Covid check. This important entry may assist democratize testing, making extra exams extra out there to folks in additional austere settings that do not have all the trimmings present in a medical workplace; together with colleges. https://t.co/QGOrBmY1pV
— Scott Gottlieb, MD (@ScottGottliebMD) August 26, 2020
The check can be utilized in docs’ places of work, emergency rooms, and even colleges, in response to the FDA assertion. It runs off a nasal swab. Then, the affected person nasal pattern will get inserted straight into the BinaxNOW card, and a coloured line seems if the check is constructive for coronavirus.
BinaxNOW works by detecting the small proteins on the floor of the coronavirus, quite than the genetic sequences of the virus itself. Tests that search for proteins, referred to as antigen exams, as a substitute of the virus are usually much less correct. Some researchers, though, argue that frequent, low-cost testing with a less-accurate check is one of the simplest ways to manage the COVID-19 pandemic.
Abbott says that the check accurately diagnoses a coronavirus an infection 97.1 % of the time, and accurately returns a destructive consequence 98.5 % of the time.
Most COVID-19 exams out there at this time must be despatched off to a lab for evaluation. This summer season, folks across the United States have reported waiting as much as every week for outcomes. “With a rapid antigen test, you get a result right away, getting infectious people off the streets and into quarantine so they don’t spread the virus,” stated Joseph Petrosino, a professor of molecular virology and microbiology at Baylor College of Medicine, in a statement from Abbott.